Jenscare Scientific Co., Ltd. (Jenscare) reported no changes to its authorised, registered or issued share capital for the month ended 30 April 2026, according to its monthly return filed with Hong Kong Exchanges and Clearing Limited on 07 May 2026.

• Authorised / Registered Capital – H-share class: 310.31 million ordinary H-shares at RMB 1 par value, unchanged from the previous month. – Unlisted shares (domestic and unlisted foreign): 106.86 million ordinary shares at RMB 1 par value, also unchanged. – Combined authorised/registered share capital remained at RMB 417.17 million.

• Issued Shares and Treasury Shares – Issued H-shares stood at 310.31 million with zero treasury shares. – Issued unlisted shares totalled 106.86 million, likewise with no treasury shares. – No new shares were issued, cancelled, repurchased or converted during the period.

• Public Float Compliance Jenscare confirmed adherence to the Main Board’s minimum public-float requirement, maintaining the initial prescribed threshold of 17.32 % of its H-shares in public hands as at 30 April 2026.

• Corporate Actions The company reported no outstanding or newly granted share options, warrants, convertible securities, or other equity-linked instruments. There were no movements under any share buy-back or treasury-share programmes.

The filing, signed by Company Secretary LI Yuanyuan, indicates a stable capital structure and full compliance with Hong Kong listing regulations during the reporting month.